MGMT and breast cancer: Further, the BG induced MGMT inhibitory effect enhancing Temozolomide cell viability inhibitory effect extends to a variety of breast cancer cells, irrespective of presence or absence of 17-β estradiol (E2) (Supplementary Figure 2 and 3).